Background: Exercise-induced bronchoconstriction (EIB) in asthmatics depends on the presence of allergic inflammation. This study was performed to assess the possible association of EIB with low-grade systemic inflammation, whose presence was revealed in asthmatic patients. Methods: The study was conducted in a group of 24 asthmatics (14 with EIB, 10 without EIB) and 8 healthy volunteers. Changes in serum and exhaled breath condensate (EBC) high-sensitivity C-reactive protein (hs-CRP) levels induced by intensive exercise were determined. Moreover, the possible correlation of these measurements with the results of other tests used in the diagnosis of asthma as well as laboratory tests commonly associated with asthma were investigated. Results: In asthmatic patients with EIB, a statistically significant increase in hs-CRP levels both in serum and EBC after an exercise test was observed. Twenty-four hours after the exercise test in the group of asthmatics with EIB, a statistically significant increase in exhaled nitric oxide (FENO), serum eosinophil cationic protein (ECP) concentrations and bronchial hyperreactivity to histamine was revealed. A statistically significant correlation between the maximum increase in hs-CRP levels both in serum and EBC after exercise and either baseline FENO and an increase in serum ECP or FENO 24 h after exercise in the group of asthmatics with EIB was revealed. Conclusions: We show that, as a result of intensive exercise leading to bronchoconstriction, an increase in serum and EBC hs-CRP occurs. Our observations could suggest that in asthmatic patients, as a consequence of exercise-induced bronchoconstriction, an intensification of low-grade systemic inflammation can be observed.

1.
Busse WW, Lemanske RF: Asthma. N Engl J Med 2001;344:350–362.
2.
Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T: The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002;89:381–385.
3.
Yoshikawa T, Shoji S, Fujii T, Kanazawa H, Kudoh S, Hirata K, Yoshikawa J: Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J 1998;12:879–884.
4.
Lee SY, Kim HB, Kim JH, Kim BS, Kang MJ, Jang SO, Hong SJ: Eosinophils play a major role in the severity of exercise-induced bronchoconstriction in children with asthma. Pediatr Pulmonol 2006;41:1161–1166.
5.
Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Szmitkowski M, Mroczko B: The role of endothelium-derived mediators in exercise-induced bronchoconstriction. Int Arch Allergy Immunol 2007;143:299–310.
6.
Tracy RP: Inflammation in cardiovascular disease: cart, horse, or both? Circulation 1998;97:2000–2002.
7.
Rifai N, Tracy RP, Ridker PM: Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45:2136–2141.
8.
Global Initiative for Asthma: Global strategy for asthma management and prevention: NHLBI/WHO Report 2005, publication 02-3659, www.ginasthma.org.
9.
American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202–1218.
10.
Ryan G, Dolovich MB, Roberts RS, Frith PA, Juniper EF, Hargreave FE, Newhouse MT: Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis 1981;123:195–199.
11.
Eggleston PA: Methods of exercise challenge. J Allergy Clin Immunol 1984;73:666–669.
12.
American Thoracic Society/American Lung Association Recommendations for On-line Measurement of Exhaled Nitric Oxide in Adults and the Recommendations for On-line, Offline and Nasal Expired Nitric Oxide Measurements in Children. Am J Respir Crit Care Med 1999;160:2104–2117.
13.
Horvath I, Hunt J, Barnes PJ: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523–548.
14.
Rahman I, Biswas S: Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep 2004;9:125–143.
15.
Multu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I: Collection and analysis of exhaled breath condensate in humans. Am Respir Crit Care Med 2001;164:731–737.
16.
Koh YI, Choi S: Blood eosinophil counts for the prediction of the severity of exercise-induced bronchospasm in asthma. Respir Med 2002;96:120–125.
17.
Venge P, Henriksen J, Dahl R: Eosinophils in exercise-induced asthma. J Allergy Clin Immunol 1991;88:699–704.
18.
Kivity S, Argaman A, Onn A, Shwartz Y, Man A, Greif J, Fireman E: Eosinophil influx into the airways in patients with exercise-induced asthma. Respir Med 2000;94:1200–1205.
19.
Zietkowski Z, Skiepko R, Tomasiak MM, Bodzenta-Lukaszyk A: Endothelin-1 in exhaled breath condensate of allergic asthma patients with exercise-induced bronchoconstriction. Respir Res 2007;8:76.
20.
Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, Skiepko R, Mroczko B, Szmitkowski M: Changes in RANTES and β-thromboglobulin after intensive exercise in patients with allergic asthma. Int Arch Allergy Immunol 2009;148:31–40.
21.
Pepys MB: C-reactive protein fifty years on. Lancet 1981;1:653–657.
22.
Nakayama T, Sonoda S, Urano T, Yamada T, Okada M: Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin Chem 1993;39:293–297.
23.
Baumann H, Gauldie J: The acute phase response. Immunol Today 1994;15:74–80.
24.
Buyukozturk S, Gelincik AA, Genc S, Kocak H, Oneriyidogan Y, Erden S, Dal M, Colakoglu B: Acute phase reactions in allergic airway disease. Tohuku J Exp Med 2004;204:209–213.
25.
Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jogi R, Janson C: C-reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005;60:451–454.
26.
Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, Jinnai M, Muro S, Hirai T, Ito Y, Nakamura T, Mio T, Chin K, Mishima H: High sensitivity C-reactive protein in asthma. Eur Respir J 2006;27:908–912.
27.
Fujita M, Ueki S, Ito W, Chiba T, Takeda M, Saito N, Kayaba H, Chihara J: C-reactive protein levels in the serum of asthmatic patients. Ann Allergy Asthma Immunol 2007;99:48–53.
28.
Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972–978.
29.
Ridker P: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813–1818.
30.
Nakamura H, Yamashita T: Predictive value of cardiovascular events by high sensitivity CRP. Nippon Rinsho 2002;60:916–921.
31.
Ueno T, Kataoka M, Hirano A, Iio K, Tanimoto Y, Kanehiro A, Okada C, Soda R, Takahashi K, Tanimoto M: Inflammatory markers in exhaled breath condensate from patients with asthma. Respirology 2008;13:654–663.
32.
Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Mroczko B, Szmitkowski M, Bodzenta-Lukaszyk A: High-sensitivity C-reactive protein in the exhaled breath and serum in stable and unstable asthma. Respir Med 2009;103:379–385.
33.
Rosias PP, Dompeling E, Dentener MA, Pennings HJ, Hendriks HJ, Van Iersel MP, Jobsis O: Childhood asthma: Exhaled markers of airway inflammation, asthma control score and lung function score. Pediatr Pulmonol 2004;38:107–114.
34.
Paivaniemi OE, Maasilta PK, Vainikka T, Alho HS, Karhunen PJ, Salminen US: Local C-reactive protein expression in obliterative lesions and the bronchial wall in posttransplant obliterative bronchiolitis. Mediators Inflamm 2009;2009:510254.
35.
Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, Taylor DR: Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004;169:473–478.
36.
Tomita H, Takamuro M, Soda W, Hatakeyama K, Tsutsumi H: Increased serum high-sensitivity C-reactive protein is related to hypoxia and brain natriuretic peptide in congenital heart disease. Pediatr Int 2008;50:436–440.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.